NovImmune SA Release: European Commission Awards a EUR 6 Million FP7 Grant to Support Clinical Development of NI-0501 to FIGHT HLH

GENEVA--(BUSINESS WIRE)--NovImmune SA announced that the European Commission has awarded a 6 million Euros FP7 grant to the “FIGHT HLH” consortium of institutions to support clinical testing of NovImmune’s anti-interferon gamma drug candidate, NI-0501.